Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TurboHawk Plus Directional Atherectomy System

K-Number: K212027 · 2021-08-24

Decision Date2021-08-24
Product CodeMCW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TurboHawk Plus Directional Atherectomy System is a medical device manufactured by Medtronic, Inc.. It received FDA 510(k) clearance on 2021-08-24 under approval number K212027. The device is classified under product code MCW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TurboHawk Plus Directional Atherectomy System?

TurboHawk Plus Directional Atherectomy System is a medical device that received FDA 510(k) clearance on 2021-08-24. It is manufactured by Medtronic, Inc.. The 510(k) number is K212027.

When was TurboHawk Plus Directional Atherectomy System approved by the FDA?

TurboHawk Plus Directional Atherectomy System received FDA 510(k) clearance on 2021-08-24, under approval number K212027.

What company makes TurboHawk Plus Directional Atherectomy System?

TurboHawk Plus Directional Atherectomy System is manufactured by Medtronic, Inc..

What is the FDA product code for TurboHawk Plus Directional Atherectomy System?

The FDA product code for TurboHawk Plus Directional Atherectomy System is MCW.

Related Clinical Trials

Other Devices by Medtronic, Inc.

View all 137 devices →

Related Devices (Code: MCW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.